Results 151 to 160 of about 10,168,516 (390)

Autoimmunity and autoimmune disease [PDF]

open access: yesNephrology Dialysis Transplantation, 2001
Katsorida, ME, Moutsopoulos, HM
openaire   +3 more sources

An Out‐of‐Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The FMR1 gene premutation (55–200 CGG repeats) is usually associated with a wide range of symptoms and phenotypes within the Fragile X‐tremor/ataxia syndrome (FXTAS), but may also manifest as predominant or isolated cognitive decline. We describe three male patients referred for progressive cognitive impairment and behavioral changes. Standard
Guido Greco   +7 more
wiley   +1 more source

Predictors of mortality in hospitalised patients with COVID-19: a 1-year case–control study

open access: yesBMJ Open
Background A paucity of predictive models assessing risk factors for COVID-19 mortality that extend beyond age and gender in Latino population is evident in the current academic literature.Objectives To determine the associated factors with mortality, in
Juan-Manuel Anaya   +17 more
doaj   +1 more source

Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease [PDF]

open access: bronze, 2017
Juliane Totzke   +15 more
openalex   +1 more source

Autoimmune Thyroid Disease [PDF]

open access: yesInternational Journal of Dermatology, 1981
Marked alterations in the level of circulating thyroid hormone frequently induce cutaneous changes. Such visible sequelae of hyperthyroidism or hypothyroidism can be among the first manilestationsot thyroid dysfunction. The etiology of such thyroid dysfunction is frequently attributable to autoimmune thyroid disease, as manifested by Graves' disease ...
openaire   +3 more sources

The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases

open access: yesMediators of Inflammation, 2017
Interleukin-17 (IL-17) induces the production of granulocyte colony-stimulating factor (G-CSF) and chemokines such as CXCL1 and CXCL2 and is a cytokine that acts as an inflammation mediator.
Taku Kuwabara   +3 more
semanticscholar   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein   +13 more
wiley   +1 more source

Targeting B Cells and Plasma Cells in Autoimmune Diseases

open access: yesFrontiers in Immunology, 2018
Success with B cell depletion using rituximab has proven the concept that B lineage cells represent a valid target for the treatment of autoimmune diseases, and has promoted the development of other B cell targeting agents.
K. Hofmann, Ann-Katrin Clauder, R. Manz
semanticscholar   +1 more source

Patterns of Postictal Abnormalities in Relation to Status Epilepticus in Adults

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Abnormalities on peri‐ictal diffusion‐weighted magnetic resonance imaging (DWI‐PMAs) are well‐established for patients with status epilepticus (SE), but knowledge on patterns of DWI‐PMAs and their prognostic impact is sparse. Methods This systematic review and individual participant data meta‐analysis included observational studies ...
Andrea Enerstad Bolle   +11 more
wiley   +1 more source

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy